Retinal Blinding Disorders and Gene Therapy - Molecular and Clinical Aspects

E-ISSN： 1875-5631|10|5|350-370

ISSN： 1566-5232

Source： Current Gene Therapy, Vol.10, Iss.5, 2010-10, pp. : 350-370

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular and Clinical Aspects of the Target Therapy with the Calcimimetic Cinacalcet in the Treatment of Parathyroid Tumors

Current Cancer Drug Targets, Vol. 15, Iss. 7, 2015-01 ,pp. : 563-574

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical aspects of preimplantation genetic diagnosis for single gene disorders combined with HLA typing

By Kahraman S Karlikaya G Sertyel S Karadayi H Findikli N

Reproductive BioMedicine Online, Vol. 9, Iss. 5, 2004-11 ,pp. : 529-532

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Neuroprotective Gene Therapy for the Treatment of Inherited Retinal Degeneration

Current Gene Therapy, Vol. 7, Iss. 6, 2007-12 ,pp. : 434-445

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Gene Therapy in the Treatment of Retinal Diseases: A Review

Current Gene Therapy, Vol. 17, Iss. 3, 2017-12 ,pp. : 194-213

Bentham Science Publishers

Access to resources Recommend Favorite

Toxicity of sorafenib: clinical and molecular aspects

By Blanchet Benoit Billemont Bertrand Barete Stéphane Garrigue Hélène Cabanes Laure Coriat Romain Francès Camille Knebelmann Bertrand Goldwasser François

Expert Opinion on Drug Safety, Vol. 9, Iss. 2, 2010-03 ,pp. : 275-287

Informa Healthcare

Access to resources Recommend Favorite